Fribourg moves to build a women’s health and exposome hub

The University of Fribourg is recruiting a new chair for Women’s Health and Exposome, a senior academic role designed to anchor research on how environmental stressors shape the prevention, pathogenesis and clinical outcomes of diseases that predominantly affect women. The appointment is set at 90% to 100% employment and carries a permanent mandate within the Faculty of Science and Medicine.

This is not a narrow departmental hire. The remit reaches across experimental, epidemiological and clinical biomedical research, with explicit emphasis on disease areas that disproportionately affect women. In practice, the post asks for a leader who can move from population-level exposure science to mechanisms of disease and then back to bedside relevance, where prevention and outcome data meet real clinical constraints.

The position also signals an institutional bet on the exposome as a framework for understanding disease risk. Environmental stressors, taken in the broad sense, can influence susceptibility, disease onset and later clinical course through biological pathways that are still being mapped. In women’s health, that approach matters because many common conditions reflect not only genetics and hormones, but also the cumulative biological imprint of living, working and aging in different environments.

A mandate that spans research, teaching and institute building

The successful candidate will be expected to develop an internationally recognized competitive research program and to help establish the envisioned Institute for Women’s Health and Exposome at Fribourg. That requirement gives the post a dual identity: it is both an academic chair and a builder’s role. The new appointee will not simply inherit a mature center; the person selected will be part of shaping the structure itself.

Teaching remains central to the appointment. Significant university-level teaching experience in human medicine is mandatory, and courses are taught in French and/or German. The bilingual setting is not incidental. Fribourg operates as Switzerland’s only fully bilingual French/German university, so the chair will need to function comfortably in a system built around two academic languages and a shared institutional culture.

A second language at B1 oral level is expected, if not already in place, and must be acquired within two years of taking up the post. For a role that combines research leadership with medical education, that language requirement is more than administrative detail. It affects supervision, classroom instruction, faculty collaboration and the day-to-day integration of the chair into the university’s clinical and scientific network.

One sentence captures the scale of the mandate plainly: the university wants a chair who can create a new research engine while also training the next generation of physicians.

Clinical collaboration is built into the job description

The chair will work closely with several major Swiss partners, including the Hôpital Fribourgeois, the University Hospital Lausanne (CHUV), the University Hospital Bern (Inselspital) and the École Polytechnique Fédérale de Lausanne (EPFL). Those links suggest a translational model rather than an isolated academic silo. Hospital partnerships point toward patient-facing disease questions, while the EPFL connection indicates room for high-level technical and interdisciplinary collaboration.

In exposome research, those partnerships are particularly relevant. Environmental exposures are often difficult to study in isolation, and the biological consequences of those exposures frequently cut across disciplines: molecular biology, epidemiology, clinical medicine, data science and public health. A chair anchored at a university but connected to major hospitals can, in principle, bridge those layers in a way that a single laboratory cannot.

The job advertisement does not specify one disease area, and that openness is meaningful. It allows the appointee to focus on female-predominant conditions where environmental contributors, disease mechanisms and outcome disparities may intersect. Conditions in this broad space often remain under-characterized in exposure science precisely because research has historically defaulted to male-dominant cohorts or generic population averages.

A search shaped by quality, equity and academic track record

Qualification requirements are exacting. Applicants must have an outstanding record of successful independent experimental, epidemiological and/or clinical biomedical research. The appointment is directed at senior scholars, not early-career investigators, and the wording makes clear that a credible publication and funding history will matter.

The university also states that it has signed the CoARA declaration and therefore emphasizes qualitative assessment of academic achievements. In hiring terms, that points away from a purely metric-driven review and toward a broader evaluation of scientific contribution, leadership and scholarly depth. For candidates whose work has crossed disciplinary boundaries, that framework may be especially important.

The institution is also explicitly seeking to promote equitable representation of women and men and strongly encourages applications from women. In the context of a chair devoted to women’s health, that emphasis aligns the recruitment process with the subject matter of the post itself. It also reflects a broader institutional effort to address representation at senior faculty level.

Why this appointment matters for women’s health research

Exposure science has become increasingly relevant to chronic disease research because many environmental influences do not act as single, isolated insults. They accumulate. Air pollution, occupational stressors, chemical exposures, social environment and other external pressures can interact with biology over time, affecting inflammation, endocrine signaling, vascular function and tissue repair. A chair focused on the exposome can push that work toward clinical questions that matter to women’s health: why some diseases emerge earlier, why severity differs, and why outcomes vary even when diagnoses look similar on paper.

The promise of the post lies in that integration. A strong program could connect cohort science, mechanistic work and hospital-based observation, then feed those findings back into prevention strategies and clinical risk assessment. In the best case, environmental medicine becomes less abstract and more actionable for patients who live with complex, female-predominant disease patterns.

The closing date for applications is 15 January 2027, and further information is available through the Faculty of Science and Medicine. For Fribourg, the hire is a strategic one: a chance to define women’s health research around exposure biology, bilingual medical teaching and cross-institutional collaboration, while giving the university a new center of gravity in a field where environmental causation is still too often treated as peripheral rather than central.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by Nature Immunology.